Galectin-3 Concentration in Liver Diseases.
Monika Gudowska-Sawczuk(Medical University of Białystok), Lech Chrostek(Medical University of Białystok), Robert Flisiak(Medical University of Białystok), Bogdan Cylwik(Medical University of Białystok), Ewa Gruszewska(Medical University of Białystok), Magdalena Rogalska(Medical University of Białystok), Anatol Panasiuk(Medical University of Białystok), Maciej Szmitkowski(Medical University of Białystok)
PubMed
January 1, 2015
Cited by 43
Related Papers
The present and future disease burden of hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infections with today's treatment paradigm – volume 2
|Journal of Viral Hepatitis|2015|125
What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?
|International Journal of Molecular Sciences|2022|96
Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in select countries – volume 2
|Journal of Viral Hepatitis|2015|93
The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review
|Journal of Clinical Medicine|2021|74
The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review
|International Journal of Molecular Sciences|2022|57